Cerner announced Aug. 20 the purchase of privately held Image Devices, a PACS developer based near Frankfurt, Germany. The acquisition will promote the continued development and enhancement of Cerner's PACS, while substantially increasing the Kansas
Cerner announced Aug. 20 the purchase of privately held Image Devices, a PACS developer based near Frankfurt, Germany. The acquisition will promote the continued development and enhancement of Cerner's PACS, while substantially increasing the Kansas City, MO, company's presence in Europe. It is expected to be nondilutive in 2002 and slightly accretive in 2003. Most of Image Devices' more than 80 European PACS installations are in Germany, Switzerland, and Austria. Additionally, its image archives are installed in more than 30 U.S. hospitals. Image Devices has been working with Cerner since 1999, developing and supplying image archive components for Cerner's ProVision PACS. The archive is a key element of Cerner's Open Image Foundation, which provides enterprise-wide image storage, according to Cerner. From now on, Image Devices will be known as "Image Devices, a Cerner company." Its PACS technology will be sold under the Cerner ProVision PACS brand name globally. All Image Devices staff will be retained and will remain located in the Aachen and Idstein, Germany, offices, according to Cerner.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.